This inventor holds 1 USPTO granted patent. Top assignee: Kaken Pharmaceutical Company, Ltd.. Active years: 1994.
Company Filing History:
Years Active: 1994
Title: Kiyoshi Nomiyama: Innovator in Bone Resorption Inhibitors
Introduction
Kiyoshi Nomiyama is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of bisphosphonic acid derivatives. His work focuses on creating effective bone resorption inhibitors, which are crucial for treating various bone-related conditions.
Latest Patents
Nomiyama holds a patent for bisphosphonic acid derivatives, which serve as bone resorption inhibitors. The patent describes a bisphosphonic acid derivative of a specific formula, which includes various chemical groups that can be modified to enhance its effectiveness. This innovation is vital for advancing treatments in bone health.
Career Highlights
Throughout his career, Kiyoshi Nomiyama has been associated with Kaken Pharmaceutical Company, Ltd. His work has led to advancements in pharmaceutical formulations that address critical health issues related to bone density and strength. His dedication to research and development has positioned him as a key figure in his field.
Collaborations
Nomiyama has collaborated with esteemed colleagues such as Yoshitaka Ohishi and Makoto Tamura. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, ultimately leading to successful outcomes in their research endeavors.
Conclusion
Kiyoshi Nomiyama's contributions to the field of pharmaceuticals, particularly through his patent on bisphosphonic acid derivatives, highlight his role as an innovator in bone health. His work continues to impact the medical community positively.